Case-control study of the relationship of depressive symptoms to suicide in a community-based sample of individuals with schizophrenia in China

Schizophrenia Research

Volumn 122, Issue 1-3, 2010, Pages 226-231

  Kasckow, John ^a,b   Liu, Nancy ^c,d   Haas, Gretchen L ^a,b   Phillips, Michael R ^c,e  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c BEIJING HUILONGGUAN HOSPITAL   (China)

^d UNIVERSITY OF NEBRASKA LINCOLN   (United States)

^e Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

China; Depression; Psychological autopsy; Schizophrenia; Suicide

Indexed keywords

ADULT; ARTICLE; CASE CONTROL STUDY; CHINA; COMMUNITY SAMPLE; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; FAMILY HISTORY; FEMALE; HUMAN; LIFE EVENT; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PRIORITY JOURNAL; RISK FACTOR; RURAL POPULATION; SCHIZOPHRENIA; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS; SUICIDE; SUICIDE ATTEMPT;

ADULT; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CHINA; DEPRESSION; FEMALE; HUMANS; INTERVIEW, PSYCHOLOGICAL; MALE; MIDDLE AGED; PREVALENCE; PSYCHIATRIC STATUS RATING SCALES; RESIDENCE CHARACTERISTICS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SUICIDE;

EID: 77956187046     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2010.02.1056     Document Type: Article

References (39)

1. Benjamini Y., Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Statist. Soc. B 1995, 57:289-300.
2. Cavanagh J.T.O., Carson A.J., Sharpe M., Lawrie S.M. Psychological autopsy studies of suicide: a systematic review. Psychol. Med. 2003, 33:395-405.
3. Conner K.R., Duberstein P.R., Conwell Y., Seidlitz L., Caine E.D. Psychological vulnerability to completed suicide: a review of empirical studies. Suicide Life-Threat. Behav. 2001, 31:367-385.
4. Dong J.Y.S., Ho T.P., Kan C.K. A case-control study of 92 cases of inpatient suicides. J Affect. Disord. 2005, 87:91-99.
5. Endicott J., Spitzer R.L. A diagnostic interview: the schedule for affective disorders and schizophrenia. Arch. Gen. Psychiatry 1978, 35:837-844.
6. Fenton W.S. Depression, suicide, and suicide prevention in schizophrenia. Suicide Life Threat. Behav. 2000, 30:34-49.
7. Freeman G.H., Halton J.H. Note on an exact treatment of contingency, goodness of fit and other problems of significance. Biometrika 1951, 38:141-149.
8. Gaynes B.N., West S.L., Ford C.A., Frame P., Klein J., Lohr K.N. U.S. Preventive Services Task Force. Screening for suicide risk in adults: a summary of the evidence for the U.S. Preventive Services Task Force. Ann. Intern. Med. 2004, 140:822-835.
9. Gilbody S., Richards D., Brealey S., Hewitt C. Screening for depression in medical settings with the Patient Health Questionnaire (PHQ): a diagnostic meta-analysis. J. Gen. Intern. Med. 2007, 22:1596-1602.
10. Hawton K., Appleby L., Platt S., Foster T., Cooper J., Malmberg A., Simkin S. The psychological autopsy method to study suicide: a review of methodological issues. J. Affect. Disord. 1998, 50:269-276.
11. Hawton K., Sutton L., Haw C., Sinclair J., Deeks J.J. Schizophrenia and suicide: systematic review of risk factors. Br. J. Psychiatry 2005, 187:9-20.
12. Heilä H., Isometsä E., Henriksson, Heikkinen M.E., Marttunen M.J., Lönnqvist J.K. Suicide and schizophrenia: a nationwide psychological autopsy study on age- and sex-specific clinical characteristics of 92 suicide victims with schizophrenia. Am. J. Psychiatry 1997, 154:1235-1242.
13. Isometsa E.T. Psychological autopsy studies-a review. Eur. Psychiatry 2001, 16:379-385.
14. Joukamaa M., Heliovaara M., Knekt P., Aromaa A., Raitasalo R., Lehtinen V. Mental disorders and cause-specific mortality. Br. J. Psychiatry 2001, 179:498-502.
15. Kan C.K., Ho T.P., Dong J.Y.S., Dunn E.L.W. Risk factors for suicide in the immediate post-discharge period. Soc. Psychiatry Psychiatr. Epidemiol. 2007, 42:208-214.
16. Kleinman A. Social origins of stress and disease: depression, neurasthenia, and pain in modern China 1986, Yale University Press, New Haven.
17. Krueger R. The structure of common mental disorders. Arch. Gen. Psychiatry 1999, 56:921-926.
18. Li J., Su J.H., Guo Y.B. A case-control study of suicide among psychiatric inpatients in the Guangzhou Psychiatric Hospital. Chin. Mental Health J. 2008, 22:8-10.
19. Meltzer H.Y., Alphs L., Green A.I., Altamura C., Anand R., Bertoldi A., Bourgeois M., Chouinard G.M., Zahur Islam M., Kane J., Krishnan R., Lindenmayer J.-P., Potkin S. Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT). Arch. Gen. Psychiatry 2003, 60:82-91.
20. Montross L., Zisook S., Kasckow J.W. Suicide among patients with schizophrenia: a consideration of risk and protective factors. Ann. Clin. Psychiatry 2005, 17:173-182.
21. Palmer B.A., Pankratz V.S., Bostwick J.M. The lifetime risk of suicide in schizophrenia: a reexamination. Arch. Gen. Psychiatry 2005, 62:247-253.
22. Phillips M.R., Yang G.H., Zhang Y.P., Wang L., Ji L., Zhou M. Risk factors for suicide in China: a national case-control psychological autopsy study. Lancet 2002, 360:1728-1736.
23. Phillips M.R., Yang G.H., Li S.R., Li Y. Suicide and the unique prevalence pattern of schizophrenia in mainland China: a retrospective observational study. Lancet 2004, 364:1062-1068.
24. Phillips M.R., Shen Q., Liu X., Pritzker S., Streiner D., Conner K., Yang G. Assessing depressive symptoms in persons who die of suicide in mainland China. J. Affect. Disord. 2007, 98:73-82.
25. Ran M.S., Chan C.L., Xiang M.Z., Wu Q.H. Suicide attempts among patients with psychosis in a Chinese rural community. Acta Psychiatr. Scand. 2003, 107:430-435.
26. Ran M.S., Wu Q.H., Conwell Y., Chen E.Y.H., Chan C.L.W. Suicidal behavior among inpatients with schizophrenia and mood disorders in Chengdu, China. Suicide Life-Threat. Behav. 2004, 34:311-319.
27. Ran M.S., Xiang M.Z., Mao W.J., Hou Z.J., Tang M.N., Chen E.Y., Chan C.L., Yip P.S. Conwell Y Characteristics of suicide attempts and nonattempters with schizophrenia in a rural community. Suicide Life-Threat. Behav. 2005, 35:694-701.
28. Ran M.S., Chen E.Y., Conwell Y., et al. Mortality in people with schizophrenia in rural China. A 10year study. Br. J. Psychiatry 2007, 190:237-242.
29. Rounsaville B.J., Alarcon R.D., Andrews G., Jackson J.S., Kendell R.E., Kendler K. Basic nomenclature issues for DSM-V. A research agenda for DSM-V 2002, 1-29. American Psychiatric Association, Washington, DC. D.J. Kupfer, M.B. First, D.E. Regier (Eds.).
30. Schwartz R.C., Cohen B.N. Psychosocial correlates of suicidal intent among patients with schizophrenia. Compr. Psychiatry 2001, 42:118-123.
31. Spina E., DeDomenico P., Ruello C., Longobardo N., Gitto C., Ancione M., Di Rosa A.E., Caputi A.P. Adjunctive fluoxetine in the treatment of negative symptoms in chronic schizophrenia. Int. Clin. Psychopharmacol. 1994, 9. 281-28.
32. Watson D. Rethinking the mood and anxiety disorders: a quantitative hierarchical model for DSM-V. J. Abnorm. Psychol. 2005, 114:522-536.
33. Widiger T.A., Coker L.A. Mental disorders as discrete clinical conditions: Dimensional versus categorical classification. Adult psychopathology and diagnosis 2003, 3-35. Wiley, New York. 4th ed. M. Hersen, S. Turner (Eds.).
34. Yang G.H., Phillips M.R., Zhou M.G., Wang L.J., Zhang Y.P., Xu D. Understanding the unique characteristics of suicide in China: national psychological autopsy study. Biomed. Environ. Sci. 2005, 18:379-389.
35. Yim P.H.W., Yip P.S.F., Li R.H.Y., Dunn E.L.W., Yeung W.S., Miao Y.K. Suicide after discharge from psychiatric inpatient care: a case-control study in Hong Kong. Aust. N.Z. J. Psychiatry 2004, 38:65-72.
36. Zhang H.S., Xiao S.Y. Suicide behaviors of inpatients with schizophrenia. Chin. Mental Health J. 2002, 16:260-262.
37. Zisook S., McAdams L.A., Kuck J., Harris M.J., Bailey A., Patterson T.L., Judd L.L., Jeste D.V. Depressive symptoms in schizophrenia. Am. J. Psychiatry 1999, 156:1736-1743.
38. Zisook S., Kasckow J., Golshan S., Fellows I., Solorzano E., Lehman D., Mohamed S., Jeste D.V. Citalopram augmentation for subsyndromal depressive symptoms in middle-aged and older patients with schizophrenia and schizoaffective disorder: a randomized controlled trial. J. Clin. Psychiatry 2009, 70:562-571.
39. Zisook, S., Kasckow, J., Golshan, S., Fellows, I., Lanouette, N., Vahia, I., Mohamed, S., Rao, S., in press. How does augmentation with citalopram affect suicidal ideation in middle-aged and older outpatients with schizophrenia and schizoaffective disorder who have subthreshold depressive symptoms? J. Clin. Psychiatry.